| Literature DB >> 23236302 |
Jean-Pierre du Plessis1, Stewart Dix-Peek, Eduard Bernard Hoffman, Nicky Wieselthaler, Robert Neil Dunn.
Abstract
STUDYEntities:
Year: 2012 PMID: 23236302 PMCID: PMC3503515 DOI: 10.1055/s-0031-1298597
Source DB: PubMed Journal: Evid Based Spine Care J ISSN: 1663-7976
Fig. 1Patient sampling and selection.
Results of x-ray measurements.
| Control x-rays (n = 58) | AOD group x-rays (n = 10) | ||||||
|---|---|---|---|---|---|---|---|
| Normal | Abnormal | Unable to measure | Normal | Abnormal | Unable to measure | ||
| BDD | 53 | 1 | 4 | 0 | 7 | 3 | <.001 |
| Powers ratio | 34 | 1 | 23 | 4 | 1 | 5 | .22 |
| Wackenheim line | 43 | 15 | 0 | 5 | 5 | 0 | .09 |
| Interspinous ratio | 56 | 2 | 0 | 1 | 9 | 0 | <.001 |
Based on Fischer's exact test comparing x-ray findings for the normal and AOD groups (among those for whom measurement was possible).
Summary of data used to determine sensitivity and specificity.
| Diagnostic Criterion | AOD present | AOD absent | Totals |
| >1 | 1 | 1 | 2 |
| <1 | 4 | 34 | 38 |
| Totals | 5 | 35 | 40 |
| not intersecting dens | 5 | 15 | 18 |
| intersecting dens | 5 | 43 | 48 |
| Totals | 10 | 58 | 66 |
| >12 mm | 7 | 1 | 8 |
| ≤12 mm | 0 | 53 | 53 |
| Totals | 7 | 54 | 61 |
| >2.5 | 9 | 2 | 11 |
| ≤2.5 | 1 | 56 | 57 |
| Totals | 10 | 58 | 68 |
Based on MRI diagnosis of AOD in 10 patients with MRI. One patients MRI was not available for review in study but reported at time of investigation as AOD. X-ray available for review.
Specificty and Sensitivity Calculations.
| Powers | 34/(1 + 34) = 97% |
| Wackenheim | 43/(15 + 43)= 74% |
| BDD | 53/(1 + 53) = 98% |
| Interspinous ration | = 56 / (2 + 56) = 97% |
| Powers | 1 / (1 + 4 ) = 20% |
| Wackenheim | 5 / (5 + 5) = 50% |
| BDD | 7 / (7 + 0) = 100% |
| Interspinous ration | 9 / (9 + 1) = 90% |
Specificity = true negative / (False positive _ true negative)
Sensitivity = True positive / (True positive + False negative)
Fig. 2The percentage sensitivity, specificity and the ability to identify the anatomical landmarks required to perform the x-ray measurement. BDD indicates basion-dens distance.
Fig. 3A lateral cervical spine x-ray showing an abnormal interspinous ratio A/B > 2.5 and increased basion-dens distance (arrow, C).
Fig. 4T2-weighted image of a patient with atlanto-occipital dissociation who had a ruptured tectorial membrane (A), cord injury (B), prevertebral soft-tissue swelling (C), and hematoma at the tip of the dens (D).
MRI features of the 9 AOD MRI's available for review.
| Prevertebral Soft tissue swelling | 7 |
| Apical ligament injury | 9 |
| Tectorial membrane elevated but intact | 5 |
| Tectorial membrane ruptured | 4 |
| Retroclival haematoma | 6 |
| Cord signal | 3 |
| Posterior interspinous ligament | 8 |
| Assessment of CoE for individual studies of diagnostic test evaluation. | |
|---|---|
| Study design | |
| Prospective cohort design | |
| Retrospective cohort design | • |
| Case-control design | |
| Methods | |
| Broad spectrum of patients with expected condition | |
| Appropriate reference standard used | |
| Adequate description of test and reference for replication | • |
| Blinded comparison with appropriate reference | |
| Reference standard performed independently of test | |
Blank box indicates criterion not met, could not be determined, or information not reported by author or was not reported.
MRI was used as the reference but only 9 of 67 patients had MRIs available for review.
The definiton for classes of evidence for diagnostic test evaluations is available in the Web Appendix at .
Patient Characteristics and clinical factors.
| AOD cases | Normal | |
|---|---|---|
| Age, years (median) | 6 (4–11) | 6 (1–12) |
| Male, n (%) | 67 | Not reported |
| Head injury | 9 | |
| Intubated | 5 | |
| Quadraplegic | 2 | |
| Cranial nerve injury | 4 | |
| Splenic rupture | 2 | |
| Limb fracture | 2 | |
| True classification | |||
|---|---|---|---|
| Diagnostic test | Disease present (+) | Disease absent (−) | |
| a = TP | b = FP | ||
| c = FN | d = TN | ||
| a + c | b + d | ||
| Term | Definition | Calculation |
|---|---|---|
| PPV = | % of patients with a positive test who have the disease | = a/(a + b) x 100 |
| NPV = | % of patents with a negative test who do NOT have the disease | = d/(c + d) x 100 |